A nomogram for predicting overall survival in patients with muscle-invasive bladder cancer undergoing radical cystectomy: a retrospective cohort study
- Haiming Huang 1,2, Han Hao 3, Jialin Du 1
- 1Department of Clinical Laboratory, Peking University First Hospital, Beijing, China.
- 2Institute of Reproductive and Child Health/National Health Commission Key Laboratory of Reproductive Health, School of Public Health, Peking University, Beijing, China.
- 3Department of Urology, Peking University First Hospital and Institute of Urology, Beijing, China.
- 0Department of Clinical Laboratory, Peking University First Hospital, Beijing, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed a prognostic nomogram to predict overall survival for muscle-invasive bladder cancer (MIBC) patients after radical cystectomy (RC). The nomogram accurately forecasts 1-, 3-, and 5-year survival, aiding clinical decision-making.
Area Of Science
- Urology
- Oncology
- Medical Statistics
Background
- Radical cystectomy (RC) is standard for muscle-invasive bladder cancer (MIBC), but survival rates are suboptimal.
- Only half of MIBC patients survive over 5 years post-RC, highlighting a need for better prognostic tools.
Purpose Of The Study
- To identify factors influencing overall survival (OS) in MIBC patients undergoing RC.
- To develop and validate a prognostic nomogram for predicting 1-, 3-, and 5-year OS after RC.
Main Methods
- Utilized data from the SEER database and Peking University First Hospital (PKUFH).
- Employed univariate and multivariate Cox regression analyses to identify independent prognostic factors.
- Constructed and validated a prognostic nomogram using Area Under the Curve (AUC) and decision curve analyses.
Main Results
- The developed nomogram demonstrated high accuracy in predicting survival (1-year AUC=0.939, 3-year AUC=0.880, 5-year AUC=0.852 in the testing set).
- The nomogram maintained good performance on an external validation dataset (1-year AUC=0.970, 3-year AUC=0.847, 5-year AUC=0.790).
- Decision curve analysis indicated a net benefit of the nomogram over American Joint Committee on Cancer staging alone.
Conclusions
- A validated prognostic nomogram can assist clinicians in assessing postoperative MIBC patient prognosis.
- Future integration of more data may enhance the model's accuracy for personalized prognostics.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

